Oxaliplatin-related thrombocytopenia is considered rare and mostly self- limited. We present the first reported fatal case due to this complication . A 64-year-old patient with metastatic colon cancer was admitted for his 24th course of chemotherapy with oxaliplatin and 24-hour infusion of fluorouracil and leucovorin. Consciousness changed on the next evening and deteriorated to deep coma within hours. Computed tomography revealed large intracranial hemorrhage with brain herniation. Hemogram showed severe thrombocytopenia, which was considered to be associated with oxaliplatin. The patient died six days later. The incidence of oxaliplatin -related thrombocytopenia may have been underestimated and its severity long neglected. Other hypersens...
Haematological adverse reactions associated with fatal outcome are rare during treatment with ciprof...
We describe 3 fatal cases of interstitial pneumonitis rapidly evolving to pulmonary fibrosis and dea...
BACKGROUND: The objective of the current prospective, multicenter, international study was to trace ...
Drug-induced acute thrombocytopenia is an extremely rare side effect that may oc-cur immediately aft...
Abstract Background Oxaliplatin is a platinum compound used in the treatment of gastrointestinal mal...
Oxaliplatin is a third-generation platinum derivative used for metastatic or advanced colorectal can...
Drug-induced immune thrombocytopenia may be poten-tially fatal; here we report the development of se...
Thrombocytopenia is a frequent complication of cancer may be due to a variety of causes including ma...
Oxaliplatin is a third generation platinum compound that inhibits DNA synthesis, mainly through intr...
We report the case of a 64-year-old patient who developed autoimmune hemolytic anemia with thrombocy...
BACKGROUND: Oxaliplatin, a third-generation platinum compound, has been implicated in isolated cas...
Oxaliplatin plus 5Fluorouracil (5FU) and leucovorin (LV) is the standard treatment of metastatic col...
Introduction. Digital ischemia is a rare complication of several chemotherapeutic medications. We ai...
Oxaliplatin immune-induced syndrome (OIIS) is an uncommon, potentially life-threatening, side effect...
Hypersensitivity reactions to oxaliplatin, either immediate or delayed-type, has been re-ported. It ...
Haematological adverse reactions associated with fatal outcome are rare during treatment with ciprof...
We describe 3 fatal cases of interstitial pneumonitis rapidly evolving to pulmonary fibrosis and dea...
BACKGROUND: The objective of the current prospective, multicenter, international study was to trace ...
Drug-induced acute thrombocytopenia is an extremely rare side effect that may oc-cur immediately aft...
Abstract Background Oxaliplatin is a platinum compound used in the treatment of gastrointestinal mal...
Oxaliplatin is a third-generation platinum derivative used for metastatic or advanced colorectal can...
Drug-induced immune thrombocytopenia may be poten-tially fatal; here we report the development of se...
Thrombocytopenia is a frequent complication of cancer may be due to a variety of causes including ma...
Oxaliplatin is a third generation platinum compound that inhibits DNA synthesis, mainly through intr...
We report the case of a 64-year-old patient who developed autoimmune hemolytic anemia with thrombocy...
BACKGROUND: Oxaliplatin, a third-generation platinum compound, has been implicated in isolated cas...
Oxaliplatin plus 5Fluorouracil (5FU) and leucovorin (LV) is the standard treatment of metastatic col...
Introduction. Digital ischemia is a rare complication of several chemotherapeutic medications. We ai...
Oxaliplatin immune-induced syndrome (OIIS) is an uncommon, potentially life-threatening, side effect...
Hypersensitivity reactions to oxaliplatin, either immediate or delayed-type, has been re-ported. It ...
Haematological adverse reactions associated with fatal outcome are rare during treatment with ciprof...
We describe 3 fatal cases of interstitial pneumonitis rapidly evolving to pulmonary fibrosis and dea...
BACKGROUND: The objective of the current prospective, multicenter, international study was to trace ...